FDA Approves Vermillion's Ovarian Cancer Test; Launch Slated for Q4

The clearance from the agency gives the company a glimmer of light as it hopes to emerge from Chapter 11 reorganization.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.